Literature DB >> 3856426

Identification of three antigens in human brain associated with similar antigens on human leukaemic cells.

E J Quackenbush, T F Cruz, M A Moscarello, M Letarte.   

Abstract

Monoclonal antibodies prepared against a non-T and non-B acute-lymphocytic-leukaemia cell line were tested for reactivity against human brain tissue. Several of the monoclonal antibodies were found to react specifically with brain fractions. Three antigens, 44H4, 44D7 and 44D10, were identified in white matter. Although 44D10 was absent from grey matter, the levels of 44H4 and 44D7 antigens present in grey matter were 2- and 4-fold higher respectively than in white matter. Fractionation of white matter indicated that all three antigens were absent from the multilamellar compact myelin, but associated with a membrane fraction of higher density. All three antigens, which required detergent for solubilization from the membranes, were purified by affinity to monoclonal antibodies and/or were analysed by immunoblotting. The 44H4 and 44D10 antigens were single polypeptide chains with Mr 94000 and 80000 respectively when resolved by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. Monoclonal antibody 44D7 reacted with a complex of a Mr greater than 120000 under non-reducing conditions in the presence of sodium dodecyl sulphate. This complex dissociated on reduction into four bands with Mr values of 80000, 57000, 47000 and 41000. The brain antigens are present on proteins similar to, or identical with, those isolated from acute-lymphocytic-leukaemia cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3856426      PMCID: PMC1144589          DOI: 10.1042/bj2250291

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes.

Authors:  A F Williams; G Galfrè; C Milstein
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

2.  The predominant heavily glycosylated glycoproteins at the surface of rat lymphoid cells are differentiation antigens.

Authors:  R Standring; W R McMaster; C A Sunderland; A F Williams
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

3.  Characterization of new non-T, non-B acute lymphoblastic leukemia cell lines: analysis of surface antigens by quantitative cellular radioimmunoassay and flow cytometry.

Authors:  J Okamura; H Okano; Y Ikuno; H Tasaka; S Motomura; M Letarte; E W Gelfand
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

4.  Purification of the Thy-1 molecule from rat brain.

Authors:  A N Barclay; M Letarte-Muirhead; A F Williams
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

5.  X-ray intensifying screens greatly enhance the detection by autoradiography of the radioactive isotopes 32P and 125I.

Authors:  R Swanstrom; P R Shank
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

6.  The isolation and characterization of an acid-soluble protein from myelin.

Authors:  J A Lowden; M A Moscarello; R Morecki
Journal:  Can J Biochem       Date:  1966-05

7.  Molecular weights of the Thy-1 glycoproteins from rat thymus and brain in the presence and absence of deoxycholate.

Authors:  P W Kuchel; D G Campbell; A N Barclay; A F Williams
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

8.  Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1.

Authors:  R C McGarry; S L Helfand; R H Quarles; J C Roder
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

9.  Chemical characterisation of the Thy-1 glycoproteins from the membranes of rat thymocytes and brain.

Authors:  A N Barclay; M Letarte-Muirhead; A F Williams; R A Faulkes
Journal:  Nature       Date:  1976-10-14       Impact factor: 49.962

10.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  8 in total

1.  Purification and characterization of the P-80 glycoprotein from human brain.

Authors:  N Girgrah; T F Cruz; M Letarte; M A Moscarello
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

2.  Purification and characterization of a protein antigen (p94) from human brain and its identification in other species.

Authors:  T F Cruz; N Girgrah; E J Quackenbush; M Letarte; M A Moscarello
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

3.  Structural heterogeneity of human Pgp-1 and its relationship with p85.

Authors:  M B Omary; I S Trowbridge; M Letarte; M F Kagnoff; C M Isacke
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 4.  Astrocytes in multiple sclerosis: a product of their environment.

Authors:  A Nair; T J Frederick; S D Miller
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

5.  The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene.

Authors:  F A Spring; R Dalchau; G L Daniels; G Mallinson; P A Judson; S F Parsons; J W Fabre; D J Anstee
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

6.  Elevated levels of a glycoprotein antigen (P-80) in gray and white matter of brain from victims of multiple sclerosis.

Authors:  T F Cruz; E J Quackenbush; M Letarte; M A Moscarello
Journal:  Neurochem Res       Date:  1986-06       Impact factor: 3.996

7.  Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types.

Authors:  L J Picker; M Nakache; E C Butcher
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

8.  Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding.

Authors:  H Haegel; C Tölg; M Hofmann; R Ceredig
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.